SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Indications -- Cancer

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
From: scaram(o)uche11/11/2013 3:00:13 PM
   of 1840
 
>> finding that IFNß also induces the expression of un-phosphorylated STAT2 (U-STAT2) and IRF9, which combine with U-STAT1 to form un-phosphorylated ISGF3 (U-ISGF3), a novel transcription factor in which these proteins form a ternary complex without tyrosine phosphorylation. <<

and.....

>> We show that prolonged exposure of cells to a low level of IFNß induces a steady state in which only the U-ISGF3-dependent genes are expressed, suggesting that secretion of IFNß by cancer cells may account for their similar phenotype. <<

IFNß-dependent increases in STAT1, STAT2, and IRF9 mediate resistance to viruses and DNA damage

HyeonJoo Cheon1, Elise G Holvey-Bates1, John W Schoggins2, Samuel Forster3, Paul Hertzog3, Naoko Imanaka2, Charles M Rice2, Mark W Jackson4, Damian J Junk4 and George R Stark1

nature.com
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext